Effect of Neurodynamic Mobilization Techniques in Patients With Diabetic Neuropathy

NCT05628168 | Completed DMC

• 1 other identifier: P.T.REC/012/003496
• Study Type: interventional
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

Neurodynamic mobilization Techniques and Selected Physical program used as a treatment for diabetic neuropathy patients and assessed by nerve condition study and function outcome.

Conditions

Diabetic Neuropathies

Keywords

Neurodynamic technique; Sensory nerve conduction study; Motor nerve conduction study; Functional outcome; Diabetic polyneuropathy.

Outcome Measures

Primary Outcomes (1)

• Effect of Neurodynamic Mobilization Techniques in Patients With Diabetic Neuropathy

  This study aimed to investigate neurodynamic mobilization effect on sensory and motor nerve conduction study, pain, and functional activity in patients with type 2 diabetic neuropathy and will be assessed through Katz index and NIHON KODEN EMG device.

  5-6 months

Study Arms (2)

Group A

EXPERIMENTAL

The NMG received three sessions/week for 4 weeks with each session lasting for 30 min including slider and tension neurodynamic techniques.

Other: Neurodynamic Mobilization Techniques; Other: Selected Physical Therapy Program

Group B

ACTIVE COMPARATOR

The participants only received a selected therapy program similar to the NMG with no change in duration.

Other: Selected Physical Therapy Program

Interventions

Neurodynamic Mobilization Techniques OTHER

The slider neurodynamic technique for the median nerve is conducted.Tensioner neurodynamic technique for the tibial nerve is conducted.

Group A

Selected Physical Therapy Program OTHER

The participants only received a selected therapy program similar to the NMG with no change in duration.

Group A; Group B

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosed with T2DM for ≥10 years determined by electrophysiological measurements were enrolled.
• The participants regularly took their diabetes medications during the assessment and treatment period.

You may not qualify if:

• Uncontrolled T2DM and diagnosed with T2DM for \< 10 years.
• Patients with neural, muscular, and skeletal system deformities; radiculopathy; and psychiatric disorders.

Sponsors & Collaborators

• October 6 University: lead

Study Sites (1)

October 6 University

El-Sheikh Zayed City, Giza Governorate, 1133, Egypt

Location

MeSH Terms

Conditions

Diabetic Neuropathies

Condition Hierarchy (Ancestors)

Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Diabetes Complications; Diabetes Mellitus; Endocrine System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer of Physical Therapy at department of Neurology

Model Details: RCT

Study Record Dates

• First Submitted: November 13, 2022
• First Posted: November 28, 2022
• Study Start: December 5, 2021
• Primary Completion: May 10, 2022
• Study Completion: June 2, 2022
• Last Updated: November 28, 2022

Record last verified: 2022-11

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)